The National Pharmaceutical Pricing Authority (NPPA) on February 28, 2024, issued the ceiling price of the Darunavir (A) +Ritonavir (B) and other formulations exclusive of Goods and Services Tax applicable, if any, in respect of the Scheduled formulation with the dosage form & strength and unit specified in the Table.
Kindly find the table attached to the document below.
[Notification No. S. O. 939(E)]